Tabu – Herpes labialis und topisches Glukokortikoid

• Literatur

• 1 Crimi S, Fiorillo L, Bianchi N. et al. Herpes virus, oral clinical signs and QoL: systematic review of recent data. Viruse 2019; 11: 463
• 2 Hull CM, Myron JL, Tyring SK. et al. Novel composite efficacy measure to demonstrate the rationale and efficacy of combination antiviral-anti-inflammatory treatment for recurrent herpes simplex labialis. Antimicrob Agents Chemother 2014; 58: 1273-1278
• 3 Evans TG, Bernstein DI, Raborn GW. et al. Double-blind, randomized, placebo-controlled study of topical 5% acyclovir – 1 % hydrocortisone cream (ME-609) for treatment of UV- radiation-induced herpes labialis. Antimicrob Agents Chemother 2002; 46: 1870-1874
• 4 da Rosa MI, Souza SL, de Farias BR. et al. Efficacy of topical 5 % Acyclovir-1 % Hydrocortisone Cream (ME-609) for treatment of herpes labialis: a systematic review. An Acad Bras Cienc 2015; 87 (2 Suppl): 1415-1420
• 5 Arain N, Paravastu SCV, Arain MA. Effectiveness of topical corticosteroids on addition to antiviral therapy in the management of recurrent herpes labialis: a systematic review and meta-analysis. BMC Infectious Diseases 2015; 15: 82